NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 327 filers reported holding NOVOCURE LTD in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,672 | -66.4% | 475 | -13.6% | 0.01% | -66.7% |
| Q2 2023 | $22,825 | -31.0% | 550 | 0.0% | 0.02% | -34.8% |
| Q1 2023 | $33,077 | -18.0% | 550 | 0.0% | 0.02% | -20.7% |
| Q4 2022 | $40,342 | -3.9% | 550 | 0.0% | 0.03% | -14.7% |
| Q3 2022 | $42,000 | +10.5% | 550 | 0.0% | 0.03% | +21.4% |
| Q2 2022 | $38,000 | -17.4% | 550 | 0.0% | 0.03% | +3.7% |
| Q1 2022 | $46,000 | +12.2% | 550 | 0.0% | 0.03% | +28.6% |
| Q4 2021 | $41,000 | -35.9% | 550 | 0.0% | 0.02% | -43.2% |
| Q3 2021 | $64,000 | -47.5% | 550 | 0.0% | 0.04% | -46.4% |
| Q2 2021 | $122,000 | +67.1% | 550 | 0.0% | 0.07% | +46.8% |
| Q1 2021 | $73,000 | -23.2% | 550 | 0.0% | 0.05% | -31.9% |
| Q4 2020 | $95,000 | +55.7% | 550 | 0.0% | 0.07% | +23.2% |
| Q3 2020 | $61,000 | +84.8% | 550 | 0.0% | 0.06% | +55.6% |
| Q2 2020 | $33,000 | -10.8% | 550 | 0.0% | 0.04% | -23.4% |
| Q1 2020 | $37,000 | -5.1% | 550 | +19.6% | 0.05% | +46.9% |
| Q4 2019 | $39,000 | +14.7% | 460 | 0.0% | 0.03% | 0.0% |
| Q3 2019 | $34,000 | +750.0% | 460 | +666.7% | 0.03% | +700.0% |
| Q2 2019 | $4,000 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |